Kamada Ltd. (KMDA) |
|
6.01 0.14 (2.39%)
|
02-25 16:00 |
|
Open: |
6.02 |
Pre. Close: |
5.87 |
|
High:
|
6.23 |
Low:
|
5.73 |
|
Volume:
|
78,450 |
Market Cap:
|
279M |
|
|
|
|
Kamada Ltd is an orphan drug, plasma-derived protein therapeutics company and develops & produces specialty plasma-derived protein therapeutics. Its flagship product include Glassia. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
6.233 - 6.264 |
6.264 - 6.295 |
|
Low:
|
5.662 - 5.692 |
5.692 - 5.722 |
|
Close:
|
5.96 - 6.009 |
6.009 - 6.059 |
|
Technical analysis |
as of: 2020-02-25 4:31:05 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 7.70 One year: 8.41 |
| Support: |
Support1: 5.60 Support2: 4.66 |
| Resistance: |
Resistance1: 6.59 Resistance2: 7.20 |
| Pivot: |
6.50  |
| Moving Average: |
MA(5): 6.04 MA(20): 6.50
MA(100): 6.26 MA(250): 5.90 |
| MACD: |
MACD(12,26): -0.18 Signal(9): -0.09 |
| Stochastic oscillator: |
%K(14,3): 16.96 %D(3): 13.05 |
| RSI: |
RSI(14): 37.54 |
| 52-week: |
High: 8.00 Low: 4.91 Change(%): -2.4 |
| Average Vol(K): |
3-Month: 5887 10-Days: 6651 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.KMDA has closed above bottom band by 21.2%. Bollinger Bands are 67.1% wider than normal. The large width of the bands suggest high volatility as compared to KMDA's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
2020-01-21
Kamada Announces US$25 Million Private Placement
Kamada has entered a purchase agreement with FIMI Opportunity Funds to purchase US$25 million of its ordinary shares in a private placement. The post Kamada Announces US$25 Million Private Placement appeared first on Investing News Network .
2019-11-26
The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Nov. 25.) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Amgen, Inc. (NASDAQ: AMGN ) Antares Pharma Inc (NASDAQ: ATRS ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Arvinas Inc (NASDAQ: ARVN ) (Guggenheim initiated coverage of stock with Buy rating and $50 price target) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) (announced achievement of enrollment target in a Phase 3 trial of drug to treat excessive daytime sleepiness and cataplexy in patients with narcolepsy) Axsome Therapeutics Inc (NASDAQ: AXSM ) Beigene Ltd (NASDAQ: BGNE ) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) BIO-TECHNE Corp (NASDAQ: TECH ) BioNTech SE – ADR (NASDAQ: BNTX ) Collegium Pharmaceutical Inc (NASDAQ: COLL ) Cue Biopharma Inc (NASDAQ: CUE ) DexCom, Inc. (NASDAQ: DXCM ) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) Epizyme Inc (NASDAQ: EPZM ) ESSA Pharma Inc (NASDAQ: EPIX ) Flexion Therapeutics Inc (NASDAQ: FLXN ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Globus Medical Inc (NYSE: GMED ) Halozyme Therapeutics, Inc.
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
